The leaky nature of tumor vasculature can be both a challenge and an opportunity for drug delivery. On one hand, the abnormal blood flow and high interstitial pressure can hinder the efficient delivery of chemotherapeutic agents. On the other hand, the enhanced permeability can be exploited to improve the uptake of nano-sized drug carriers, a concept known as the Enhanced Permeability and Retention (EPR) effect.
